Janus Henderson Group

Janus Henderson Group Portfolio holdings

AUM $219B
1-Year Est. Return 30.56%
 

Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.

This Quarter Est. Return
1 Year Est. Return
+30.56%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$204B
AUM Growth
+$21.6B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
2,542
New
Increased
Reduced
Closed

Top Buys

1 +$549M
2 +$467M
3 +$441M
4
AVGO icon
Broadcom
AVGO
+$350M
5
CSGP icon
CoStar Group
CSGP
+$320M

Top Sells

1 +$1.62B
2 +$570M
3 +$562M
4
MA icon
Mastercard
MA
+$313M
5
JNJ icon
Johnson & Johnson
JNJ
+$300M

Sector Composition

1 Technology 36.59%
2 Healthcare 15.91%
3 Consumer Discretionary 10.83%
4 Financials 10.24%
5 Industrials 8.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARHS icon
2351
Arhaus
ARHS
$1.52B
$163K ﹤0.01%
18,800
-22,457
EOLS icon
2352
Evolus
EOLS
$452M
$163K ﹤0.01%
17,642
CAPR icon
2353
Capricor Therapeutics
CAPR
$1.25B
$163K ﹤0.01%
16,400
WEAV icon
2354
Weave Communications
WEAV
$521M
$162K ﹤0.01%
19,500
STGW icon
2355
Stagwell
STGW
$1.44B
$162K ﹤0.01%
36,001
GDRX icon
2356
GoodRx Holdings
GDRX
$916M
$162K ﹤0.01%
32,452
ARCO icon
2357
Arcos Dorados Holdings
ARCO
$1.53B
$159K ﹤0.01%
20,106
GRABW icon
2358
Grab Holdings Warrant
GRABW
$9.24M
$158K ﹤0.01%
403,754
LAB icon
2359
Standard BioTools
LAB
$554M
$157K ﹤0.01%
131,610
MLYS icon
2360
Mineralys Therapeutics
MLYS
$2.91B
$157K ﹤0.01%
+11,600
IOVA icon
2361
Iovance Biotherapeutics
IOVA
$893M
$157K ﹤0.01%
91,341
BGS icon
2362
B&G Foods
BGS
$371M
$156K ﹤0.01%
36,938
JELD icon
2363
JELD-WEN Holding
JELD
$226M
$151K ﹤0.01%
38,579
HGTY icon
2364
Hagerty
HGTY
$1.26B
$150K ﹤0.01%
14,933
-37,634
NUVB icon
2365
Nuvation Bio
NUVB
$2.74B
$150K ﹤0.01%
76,700
JBLU icon
2366
JetBlue
JBLU
$1.8B
$148K ﹤0.01%
34,995
NFE icon
2367
New Fortress Energy
NFE
$396M
$146K ﹤0.01%
44,020
-100,705
RES icon
2368
RPC Inc
RES
$1.29B
$144K ﹤0.01%
30,555
SLQT icon
2369
SelectQuote
SLQT
$241M
$143K ﹤0.01%
60,100
RBBN icon
2370
Ribbon Communications
RBBN
$514M
$143K ﹤0.01%
35,625
CTOS icon
2371
Custom Truck One Source
CTOS
$1.35B
$142K ﹤0.01%
28,800
CGEM icon
2372
Cullinan Oncology
CGEM
$730M
$139K ﹤0.01%
18,528
DAWN icon
2373
Day One Biopharmaceuticals
DAWN
$847M
$139K ﹤0.01%
21,300
OPEN icon
2374
Opendoor
OPEN
$7.07B
$134K ﹤0.01%
259,332
RLAY icon
2375
Relay Therapeutics
RLAY
$1.31B
$128K ﹤0.01%
36,873